NORTHBROOK, Ill. -- More than 1,500 researchers, physicians and scientists from around the world who specialize in tropical medicine and parasitology will meet at the 53rd American Society of Tropical Medicine and Hygiene annual meeting Nov. 7-11, 2004 in Miami to present and discuss the latest study findings and science related to
preventing, treating and diagnosing life-threatening infectious diseases.
Representatives from countries including Peru, West Africa, Tanzania,
Zambia, Argentina, members of the World Health Organization, the Centers for
Disease Control and the National Institutes of Health and members of the U.S.
Army Medical Research Institute of Infectious Diseases, the U.S. Army Center
for Health Promotion and Preventive Medicine, and Walter Reed Army Institute
of Research will be at the meeting to address topics concerning global health
including:
-- The latest preventive methods for diseases that pose bioterrorism
threats, including smallpox, plague, botulism, tularemia and
hemorrhagic fevers
-- Diseases affecting members of the active military
-- Immigrant and refugee health, including immunizations and women's
health issues
-- Polio eradication worldwide
-- Parasites in the human blood supply
-- New developments in vaccines for SARS, Ebola virus and malaria
The ASTMH was formed in 1951 with the amalgamation of the American Society
of Tropical Medicine, founded in 1903, and the National Malaria Society,
founded in 1940. The ASTMH is the principal organization in the United States
representing scientists, clinicians and others with interests in the
prevention and control of tropical and infectious diseases through research
and education.
Source: American Society of Tropical Medicine and Hygiene
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.